SPY411.49+2.97 0.73%
DIA337.86+2.73 0.81%
IXIC13,900.19+70.88 0.51%

GlaxoSmithKline, Medicago to Launch Phase 3 Study of Adjuvanted COVID-19 Vaccine Candidate

· 03/16/2021 05:14

Please log in to view news